In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
491 News Items found
MSK Postdoc Luis Felipe Somarribas Patterson in the lab
MSK Postdoc Spotlight: Luis Felipe Somarribas Patterson

Luis Felipe Somarribas Patterson joined the Santosha Vardhana Lab as a postdoc in 2021. He investigates how metabolism influences different cell types, including immune cells, and conducts research into “exhausted T cells,” a state of T cell dysfunction that arises during chronic infections and cancer.
To our Community
A Message From Dr. Selwyn Vickers, MSK’s President and CEO

Learn about immunotherapy advances for cancer treatment from Dr. Selwyn Vickers, President and CEO of Memorial Sloan Kettering.
Microscopy image showing a quiescent cluster of lung adenocarcinoma tumor cells with low STING expression.
MSK Scientists Identify Potential New Strategy Against Metastasis

A team of scientists at the Sloan Kettering Institute has identified the STING cellular signaling pathway as a key player in keeping dormant cancer cells from progressing into aggressive tumors months, or even years, after they’ve escaped from a primary tumor.
Nadeem Riaz (left) and Jorge Reis-Filho (right)
For People with Certain BRCA Mutations, Activating the Immune System Could Be Promising Treatment

Human data and results from mouse experiments suggest that people with BRCA2 mutations may respond well to immunotherapy drugs.
Karen Granville
Karen Granville Believes in Paying it Forward for Women’s History Month

Karen Granville works as a patient advocate to increase their access to MSK for cancer treatment.
Memorial Sloan Kettering researchers Luc Morris and Nils Weinhold
Machine Learning Approach Takes MSK Researchers Beyond Known Method to Predict Immunotherapy Response

Learn about recent research led by MSK physician-scientist Luc Morris, who is trying to better predict who will benefit from immunotherapy.
Philipp Niethammer
Playing with Fire: Fish, Ferroptosis, and the Combustible Chemistry of Wound Detection

Cell biologists are finding surprising overlaps between a particular form of programmed cell death and the process of wound detection.
Andi Straus and her son, Nadav, pose on a hiking trail.
Targeted Therapy Shows Promising Results Against Rare Soft Tissue Sarcoma

A clinical trial led by doctors from MSK has found that abemaciclib — a drug already approved for certain breast cancers — can significantly slow the growth of dedifferentiated liposarcoma, a rare, aggressive soft tissue cancer.
Announcement
Eleven Scientists Join World-Renowned Faculty at Gerstner Sloan Kettering

Meet the 11 new faculty members that have joined the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences.
Rihanna sitting in a chair outside
Feature
Getting to the Root of Pediatric Cancers

MSK Kids is leading a major effort to fully deliver on the promise of precision medicine for our youngest patients.